Wales
Antiverse receive investment from IIC and Development Bank of Wales
March 9, 2026Research and Development Antiverse, Wales, funding
As part of its $9.3m Series A funding round, Antiverse has received a joint equity investment by Innovation Investment Capital …
Shionogi’s Mulpleo recommended for NHS use across England, Wales and Scotland for chronic liver disease
December 12, 2019Sales and Marketing England, Mulpleo, NICE, Scotland, Scottish Medicines Consortium, Shionogi, Wales
Both the regulators governing NHS use of medicines in England, Wales and Scotland – the National Institute for Health and …
Public satisfaction with NHS falls to lowest point since 2007
March 7, 2019Medical Communications England, King's, NHS, Nuffield, Scotland, UK, Wales, kings, public stisfaction
Public satisfaction with the NHS has fallen to lowest levels since 2007, according to analysis of the 2018 British Social …
More children suffering from type 2 diabetes in England and Wales
August 20, 2018Sales and Marketing England, NHS, Wales, children, diabetes, obesity, young people
The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past …
NICE recommends Eli Lilly’s psoriatic arthritis drug
August 9, 2018Research and Development, Sales and Marketing Eli Lilly, England, NICE, Wales, psoriatic arthritis
Eli Lilly have announced that the monoclonal antibody ixekizumab, has been recommended by NICE for use as a treatment option …
Essentra packaging facility co-funded by Welsh Government to close
July 27, 2017Manufacturing and Production Essentra, Wales, Welsh Government, biotech, drugs, packaging, pharma, pharmaceutical
Essentra, a manufacturer of packaging for the pharmaceutical and retail industry, has revealed that it is undergoing a consultation process …
Welsh government launches £80 million fund for newly approved drugs
January 13, 2017Medical Communications Wales, Welsh Government, drug fund
The Welsh Government has created a five-year £80 million drug fund, which will work out to an additional £16 million …
Wales approve pancreatic cancer drug for use despite NICE rejection in England
March 18, 2016Medical Communications, Research and Development Abraxane, Celgene, England, NHS, NICE, Wales, approval
Celgene (Nasdaq: CELG) has announced that Abraxane, in combination with gemcitabine, will continue to be an available treatment option for …
Norgine opens new £4.5 million warehouse
November 17, 2015Manufacturing and Production, Research and Development Norgine, Temperature control, Wales, manufacturing, production, temperature-control
Norgine has opened a new £4.5 million temperature controlled warehouse on its current site in Hengoed, Wales. The Dutch-based firm …
Wales Assembly facing questions over cancer
November 5, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, Wales, Welsh, assembly, drugs fund, oncology
The state of cancer services in Wales has come under increased scrutiny this week as the country’s ability to provide …
Life Sciences Hub Wales – new COO and
 board


June 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Hub Wales, Wales, ian barwick
Dr Ian Barwick has been appointed chief operating officer for Life Sciences Hub Wales along with several new board members.
 …
Penn Pharma starts operations
June 9, 2014Manufacturing and Production, Sales and Marketing API, Penn Pharma, Wales, manufacturing, south
Penn Pharma has opened its expanded facility in South Wales, after a £3 million investment which will allow it to …
‘Inequality’ for Welsh cancer patients
August 28, 2013Sales and Marketing CDF, Cancer, England, NHS, NICE, Wales
Cancer sufferers in England are four times more likely to receive newer treatments on the NHS than patients in Wales, …
ReNeuron relocates to Wales
July 22, 2013Research and Development, Sales and Marketing ReNeuron, Wales, stem cell, stroke
The Welsh government is to fork out a £7.8 million grant package to get English stem cell research company ReNeuron …
Cancer Drugs Fund ‘the wrong choice’ for Wales
May 29, 2012Sales and Marketing CDF, Cancer, NHS, Wales, Welsh
The Welsh health minister Lesley Griffiths has said that a Cancer Drugs Fund is ‘not the right course’ for Wales. …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
